Evaluation of the Effect of a Peer-Support App on HbA1c Improvement in Patients with Type 2 diabetes mellitus

UMIN ID: UMIN000056609

Registered date:10/01/2025

Basic Information

• Recruitment status: Complete: follow-up continuing
• Health condition(s) or Problem(s) studied: Type 2 diabetes mellitus
• Date of first enrollment: 2023/08/01
• Target sample size: 100
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

The app usage group will share blood glucose management reports in teams of five and conduct measurements of body weight, blood pressure, and blood tests at 12 and 24 weeks.
The non-usage group will work on achieving their goals individually without sharing results. Measurements of body weight, blood pressure, and blood tests will be conducted at 12 and 24 weeks.

Outcome(s)

• Primary Outcome: Between-group comparison of changes in HbA1c levels from baseline to week 24 of the treatment period

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: 74years-old
• Gender: Male and Female
• Exclude criteria: 1.Difficulty communicating in Japanese 2.Unable to walk independently 3.Previously used this app

Related Information

• Primary Sponsor: University of Yamanashi Hospital
• Secondary Sponsor: Yamanashi Prefectural Central Hospital Enzan Citizen Hospital Ichikawa Medical Clinic Kitamura Clinic Nakazato Medical Clinic National Hospital Organization Kofu National Hospital Fuefuki Central Hospital Chuo Internal Medicine Clinic Fujiyoshida Municipal Hospital
• Source(s) of Monetary Support: A10 Lab Inc.